Current concepts on the molecular biology of osteosarcoma

Richard Gorlick

Research output: Chapter in Book/Report/Conference proceedingConference contribution

84 Citations (Scopus)

Abstract

Despite the knowledge of many of the genetic alterations present in osteosarcoma, its complexity precludes placing its biology into a simple conceptual framework. In contrast to many other malignancies, multiple genetic and environmental factors can all lead to the development of osteosarcoma which is defined phenotypically rather than molecularly. Despite the many factors capable of leading to its development, osteosarcoma is a rare malignancy that is relatively homogeneous in its clinical behavior and chemotherapy response. It remains unknown whether the clinical features of osteosarcoma are defined by the cell of origin, the genetic events leading to transformation, the timing of those events or factors related to differentiation into an osteoblastic phenotype. Identifying new treatment approaches has generally been through empiric and screening approaches. In this presentation the genetic alterations present in osteosarcoma, issues related to the cell of origin and bone differentiation will be reviewed along with the recent results of preclinical drug screening.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
Pages467-478
Number of pages12
Volume152
DOIs
StatePublished - 2009

Publication series

NameCancer Treatment and Research
Volume152
ISSN (Print)09273042

Fingerprint

Osteosarcoma
Molecular Biology
Preclinical Drug Evaluations
Neoplasms
Phenotype
Bone and Bones
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Gorlick, R. (2009). Current concepts on the molecular biology of osteosarcoma. In Cancer Treatment and Research (Vol. 152, pp. 467-478). (Cancer Treatment and Research; Vol. 152). https://doi.org/10.1007/978-1-4419-0284-9_27

Current concepts on the molecular biology of osteosarcoma. / Gorlick, Richard.

Cancer Treatment and Research. Vol. 152 2009. p. 467-478 (Cancer Treatment and Research; Vol. 152).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Gorlick, R 2009, Current concepts on the molecular biology of osteosarcoma. in Cancer Treatment and Research. vol. 152, Cancer Treatment and Research, vol. 152, pp. 467-478. https://doi.org/10.1007/978-1-4419-0284-9_27
Gorlick R. Current concepts on the molecular biology of osteosarcoma. In Cancer Treatment and Research. Vol. 152. 2009. p. 467-478. (Cancer Treatment and Research). https://doi.org/10.1007/978-1-4419-0284-9_27
Gorlick, Richard. / Current concepts on the molecular biology of osteosarcoma. Cancer Treatment and Research. Vol. 152 2009. pp. 467-478 (Cancer Treatment and Research).
@inproceedings{02c2e7e0442c47ac864c7bedcbeb2e6a,
title = "Current concepts on the molecular biology of osteosarcoma",
abstract = "Despite the knowledge of many of the genetic alterations present in osteosarcoma, its complexity precludes placing its biology into a simple conceptual framework. In contrast to many other malignancies, multiple genetic and environmental factors can all lead to the development of osteosarcoma which is defined phenotypically rather than molecularly. Despite the many factors capable of leading to its development, osteosarcoma is a rare malignancy that is relatively homogeneous in its clinical behavior and chemotherapy response. It remains unknown whether the clinical features of osteosarcoma are defined by the cell of origin, the genetic events leading to transformation, the timing of those events or factors related to differentiation into an osteoblastic phenotype. Identifying new treatment approaches has generally been through empiric and screening approaches. In this presentation the genetic alterations present in osteosarcoma, issues related to the cell of origin and bone differentiation will be reviewed along with the recent results of preclinical drug screening.",
author = "Richard Gorlick",
year = "2009",
doi = "10.1007/978-1-4419-0284-9_27",
language = "English (US)",
isbn = "9781441902832",
volume = "152",
series = "Cancer Treatment and Research",
pages = "467--478",
booktitle = "Cancer Treatment and Research",

}

TY - GEN

T1 - Current concepts on the molecular biology of osteosarcoma

AU - Gorlick, Richard

PY - 2009

Y1 - 2009

N2 - Despite the knowledge of many of the genetic alterations present in osteosarcoma, its complexity precludes placing its biology into a simple conceptual framework. In contrast to many other malignancies, multiple genetic and environmental factors can all lead to the development of osteosarcoma which is defined phenotypically rather than molecularly. Despite the many factors capable of leading to its development, osteosarcoma is a rare malignancy that is relatively homogeneous in its clinical behavior and chemotherapy response. It remains unknown whether the clinical features of osteosarcoma are defined by the cell of origin, the genetic events leading to transformation, the timing of those events or factors related to differentiation into an osteoblastic phenotype. Identifying new treatment approaches has generally been through empiric and screening approaches. In this presentation the genetic alterations present in osteosarcoma, issues related to the cell of origin and bone differentiation will be reviewed along with the recent results of preclinical drug screening.

AB - Despite the knowledge of many of the genetic alterations present in osteosarcoma, its complexity precludes placing its biology into a simple conceptual framework. In contrast to many other malignancies, multiple genetic and environmental factors can all lead to the development of osteosarcoma which is defined phenotypically rather than molecularly. Despite the many factors capable of leading to its development, osteosarcoma is a rare malignancy that is relatively homogeneous in its clinical behavior and chemotherapy response. It remains unknown whether the clinical features of osteosarcoma are defined by the cell of origin, the genetic events leading to transformation, the timing of those events or factors related to differentiation into an osteoblastic phenotype. Identifying new treatment approaches has generally been through empiric and screening approaches. In this presentation the genetic alterations present in osteosarcoma, issues related to the cell of origin and bone differentiation will be reviewed along with the recent results of preclinical drug screening.

UR - http://www.scopus.com/inward/record.url?scp=77953666099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953666099&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-0284-9_27

DO - 10.1007/978-1-4419-0284-9_27

M3 - Conference contribution

C2 - 20213409

AN - SCOPUS:77953666099

SN - 9781441902832

VL - 152

T3 - Cancer Treatment and Research

SP - 467

EP - 478

BT - Cancer Treatment and Research

ER -